Beranda › Kanker Laring › Michigan › Canton
Uji klinis Kanker Laring di Canton, MI
3 studi untuk Kanker Laring mencari peserta di lokasi sekitar Canton (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Menerima pesertaFase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Menerima pesertaFase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Menerima pesertaFase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Uji klinis Kanker Laring di kota lain
- Atlanta, GA8 studi
- Chicago, IL8 studi
- Milwaukee, WI8 studi
- Kansas City, MO7 studi
- Portland, OR7 studi
- St. Louis, MO7 studi
- Baltimore, MD6 studi
- Cincinnati, OH6 studi
- Edison, NJ6 studi
- Richmond, VA6 studi
- Durham, NC6 studi
- Pittsburgh, PA6 studi
Studi lain di Canton
- Kanker Paru9 studi
- Kanker Paru Non-Sel Kecil8 studi
- Kanker Prostat8 studi
- Leukemia Mieloid Akut7 studi
- Kanker Kolorektal6 studi
- Kanker Ginjal (Karsinoma Sel Renal)5 studi
- Kanker Ovarium4 studi
- Kanker Kandung Kemih4 studi
- Kanker Payudara4 studi
- Kanker Esofagus3 studi
- Kanker Lambung3 studi
- Kanker Pankreas3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.